|
🐜
|
Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
12 auth.
Christian Dölle,
I. Flønes,
Gonzalo S. Nido,
H. Miletic,
Nelson Osuagwu,
S. Kristoffersen,
...
P. Lilleng,
J. Larsen,
O. Tysnes,
K. Haugarvoll,
L. Bindoff,
C. Tzoulis
|
7 |
2016 |
7
🐜
|
|
🐜
|
Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases.
33 auth.
B. Oftedal,
Alexander Hellesen,
Alexander Hellesen,
Martina M Erichsen,
E. Bratland,
Ayelet Vardi,
J. Perheentupa,
E. Kemp,
Torunn Fiskerstrand,
Torunn Fiskerstrand,
M. K. Viken,
A. Weetman,
S. Fleishman,
Siddharth Banka,
Siddharth Banka,
...
William G. Newman,
William G. Newman,
W.A.C. Sewell,
L. Sozaeva,
T. Zayats,
K. Haugarvoll,
E. Orlova,
J. Haavik,
Stefan Johansson,
Stefan Johansson,
P. Knappskog,
P. Knappskog,
K. Løvås,
K. Løvås,
A. Wolff,
J. Abramson,
E. Husebye,
E. Husebye
|
7 |
2015 |
7
🐜
|
|
🐜
|
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.
8 auth.
M. Farrer,
J. T. Stone,
Chin-Hsien Lin,
J. Dächsel,
M. Hulihan,
K. Haugarvoll,
...
O. Ross,
R. Wu
|
7 |
2007 |
7
🐜
|
|
🐜
|
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
20 auth.
Brage Brakedal,
Christian Dölle,
F. Riemer,
Yilong Ma,
Gonzalo S. Nido,
G. Skeie,
A. Craven,
T. Schwarzlmüller,
N. Brekke,
Joseph Diab,
...
L. Sverkeli,
Vivian Skjeie,
K. Varhaug,
O. Tysnes,
S. Peng,
K. Haugarvoll,
M. Ziegler,
R. Grüner,
D. Eidelberg,
C. Tzoulis
|
7 |
2022 |
7
🐜
|
|
🦁
|
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseSYMBOL
37 auth.
K. Haugarvoll,
K. Haugarvoll,
R. Rademakers,
R. Rademakers,
J. Kachergus,
Karen Nuytemans,
O. Ross,
J. Gibson,
E. Tan,
C. Gaig,
E. Tolosa,
S. Goldwurm,
M. Guidi,
G. Riboldazzi,
L. Brown,
...
U. Walter,
R. Benecke,
D. Berg,
T. Gasser,
T. Gasser,
J. Theuns,
P. Pals,
P. Cras,
P. P. Deyn,
S. Engelborghs,
B. Pickut,
R. Uitti,
T. Foroud,
W. Nichols,
J. Hagenah,
C. Klein,
A. Samii,
C. Zabetian,
V. Bonifati,
C. Broeckhoven,
M. Farrer,
Z. Wszolek
|
7 |
2008 |
7
🦁
|
|
🦁
|
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseSYMBOL
37 auth.
K. Haugarvoll,
K. Haugarvoll,
R. Rademakers,
R. Rademakers,
J. Kachergus,
Karen Nuytemans,
O. Ross,
J. Gibson,
E. Tan,
C. Gaig,
E. Tolosa,
S. Goldwurm,
M. Guidi,
G. Riboldazzi,
L. Brown,
...
U. Walter,
R. Benecke,
D. Berg,
T. Gasser,
T. Gasser,
J. Theuns,
P. Pals,
P. Cras,
P. P. Deyn,
S. Engelborghs,
B. Pickut,
R. Uitti,
T. Foroud,
W. Nichols,
J. Hagenah,
C. Klein,
A. Samii,
C. Zabetian,
V. Bonifati,
C. Broeckhoven,
M. Farrer,
Z. Wszolek
|
7 |
2008 |
7
🦁
|
|
🐜
|
α-Synuclein and Parkinson disease susceptibility
9 auth.
Susen Winkler,
J. Hagenah,
Sarah Lincoln,
Michael G. Heckman,
K. Haugarvoll,
K. Lohmann‐Hedrich,
...
Vladimir S. Kostić,
M. Farrer,
C. Klein
|
7 |
2007 |
7
🐜
|
|
🐜
|
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
19 auth.
J. Aasly,
C. Vilariño-Güell,
J. Dachsel,
P. Webber,
A. West,
K. Haugarvoll,
K. Johansen,
M. Toft,
J. Nutt,
H. Payami,
...
J. Kachergus,
S. Lincoln,
Amela Felic,
C. Wider,
A. Soto-Ortolaza,
S. A. Cobb,
L. White,
O. Ross,
M. Farrer
|
6 |
2010 |
6
🐜
|
|
🦁
|
MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing
9 auth.
K. Haugarvoll,
S. Johansson,
C. Tzoulis,
B. Haukanes,
C. Bredrup,
G. Neckelmann,
...
H. Boman,
P. Knappskog,
L. Bindoff
|
6 |
2013 |
6
🦁
|
|
🐜
|
Neuronal complex I deficiency occurs throughout the Parkinson’s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage
13 auth.
I. Flønes,
E. Fernández-Vizarra,
Maria Lykouri,
Brage Brakedal,
G. Skeie,
H. Miletic,
P. Lilleng,
G. Alves,
O. Tysnes,
K. Haugarvoll,
...
Christian Dölle,
M. Zeviani,
C. Tzoulis
|
6 |
2018 |
6
🐜
|
